HEALTHPEAK PROPERTIES INC (DOC) Fundamental Analysis & Valuation
NYSE:DOC • US42250P1030
17.045 USD
+0.15 (+0.86%)
Last: Mar 13, 2026, 02:38 PM
This DOC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
We assign a fundamental rating of 3 out of 10 to DOC. DOC was compared to 123 industry peers in the Diversified REITs industry. DOC has a medium profitability rating, but doesn't score so well on its financial health evaluation. DOC is quite expensive at the moment. It does show a decent growth rate.
1. DOC Profitability Analysis
1.1 Basic Checks
- In the past year DOC was profitable.
- DOC had a positive operating cash flow in the past year.
- DOC had positive earnings in each of the past 5 years.
- Each year in the past 5 years DOC had a positive operating cash flow.
1.2 Ratios
- DOC's Return On Assets of 0.35% is in line compared to the rest of the industry. DOC outperforms 45.53% of its industry peers.
- Looking at the Return On Equity, with a value of 0.94%, DOC is in line with its industry, outperforming 47.15% of the companies in the same industry.
- DOC has a Return On Invested Capital (2.24%) which is comparable to the rest of the industry.
- Measured over the past 3 years, the Average Return On Invested Capital for DOC is in line with the industry average of 3.11%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROIC | 2.24% |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
1.3 Margins
- DOC has a Profit Margin of 2.50%. This is comparable to the rest of the industry: DOC outperforms 45.53% of its industry peers.
- DOC's Profit Margin has declined in the last couple of years.
- The Operating Margin of DOC (19.31%) is comparable to the rest of the industry.
- In the last couple of years the Operating Margin of DOC has grown nicely.
- DOC's Gross Margin of 60.00% is on the low side compared to the rest of the industry. DOC is outperformed by 67.48% of its industry peers.
- In the last couple of years the Gross Margin of DOC has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% |
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
2. DOC Health Analysis
2.1 Basic Checks
- DOC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- DOC has less shares outstanding than it did 1 year ago.
- DOC has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, DOC has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 0.33, we must say that DOC is in the distress zone and has some risk of bankruptcy.
- DOC has a Altman-Z score (0.33) which is comparable to the rest of the industry.
- DOC has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
- DOC's Debt to Equity ratio of 1.27 is in line compared to the rest of the industry. DOC outperforms 47.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.33 |
ROIC/WACC0.38
WACC5.92%
2.3 Liquidity
- A Current Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
- The Current ratio of DOC (0.48) is worse than 74.80% of its industry peers.
- A Quick Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
- DOC's Quick ratio of 0.48 is on the low side compared to the rest of the industry. DOC is outperformed by 74.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 |
3. DOC Growth Analysis
3.1 Past
- DOC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
- DOC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.06% yearly.
- Looking at the last year, DOC shows a small growth in Revenue. The Revenue has grown by 4.52% in the last year.
- DOC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.40% yearly.
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
3.2 Future
- The Earnings Per Share is expected to grow by 0.77% on average over the next years.
- The Revenue is expected to grow by 5.62% on average over the next years.
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue Next Year1.4%
Revenue Next 2Y2.68%
Revenue Next 3Y3.92%
Revenue Next 5Y5.62%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. DOC Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 48.70, DOC can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Earnings ratio of DOC is on the same level as its industry peers.
- DOC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.71.
- The Price/Forward Earnings ratio is 78.49, which means the current valuation is very expensive for DOC.
- DOC's Price/Forward Earnings is on the same level as the industry average.
- DOC is valuated expensively when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.7 | ||
| Fwd PE | 78.49 |
4.2 Price Multiples
- DOC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DOC is cheaper than 65.04% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.17 |
4.3 Compensation for Growth
- A cheap valuation may be justified as DOC's earnings are expected to decrease with -9.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
5. DOC Dividend Analysis
5.1 Amount
- DOC has a Yearly Dividend Yield of 7.01%, which is a nice return.
- DOC's Dividend Yield is a higher than the industry average which is at 7.59.
- DOC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.01% |
5.2 History
- The dividend of DOC decreases each year by -4.20%.
- DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-4.2%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- DOC pays out 1204.15% of its income as dividend. This is not a sustainable payout ratio.
DP1204.15%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
DOC Fundamentals: All Metrics, Ratios and Statistics
NYSE:DOC (3/13/2026, 2:38:04 PM)
17.045
+0.15 (+0.86%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-02 2026-02-02/amc
Earnings (Next)04-22 2026-04-22
Inst Owners97.68%
Inst Owner Change-96.4%
Ins Owners0.23%
Ins Owner Change1.26%
Market Cap11.85B
Revenue(TTM)2.82B
Net Income(TTM)70.51M
Analysts73.91
Price Target19.83 (16.34%)
Short Float %4.51%
Short Ratio3.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.01% |
Yearly Dividend1.22
Dividend Growth(5Y)-4.2%
DP1204.15%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2026-03-17 (0.10167)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.65%
Min EPS beat(2)37.75%
Max EPS beat(2)179.54%
EPS beat(4)3
Avg EPS beat(4)52.57%
Min EPS beat(4)-19.41%
Max EPS beat(4)179.54%
EPS beat(8)5
Avg EPS beat(8)31.44%
EPS beat(12)8
Avg EPS beat(12)38.23%
EPS beat(16)11
Avg EPS beat(16)56.93%
Revenue beat(2)2
Avg Revenue beat(2)1.99%
Min Revenue beat(2)0.94%
Max Revenue beat(2)3.04%
Revenue beat(4)3
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.04%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)9
Avg Revenue beat(12)-4.49%
Revenue beat(16)11
Avg Revenue beat(16)-3.26%
PT rev (1m)-2.2%
PT rev (3m)-5.32%
EPS NQ rev (1m)-4%
EPS NQ rev (3m)-3.23%
EPS NY rev (1m)-17.76%
EPS NY rev (3m)-18.7%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-1.17%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-1.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.7 | ||
| Fwd PE | 78.49 | ||
| P/S | 4.2 | ||
| P/FCF | N/A | ||
| P/OCF | 9.46 | ||
| P/B | 1.58 | ||
| P/tB | 1.75 | ||
| EV/EBITDA | 13.17 |
EPS(TTM)0.35
EY2.05%
EPS(NY)0.22
Fwd EY1.27%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)1.8
OCFY10.57%
SpS4.06
BVpS10.79
TBVpS9.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROCE | 2.84% | ||
| ROIC | 2.24% | ||
| ROICexc | 2.3% | ||
| ROICexgc | 2.51% | ||
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% | ||
| FCFM | N/A |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
ROICexc(3y)2.3%
ROICexc(5y)2.18%
ROICexgc(3y)2.51%
ROICexgc(5y)2.37%
ROCE(3y)2.87%
ROCE(5y)2.73%
ROICexgc growth 3Y5.01%
ROICexgc growth 5Y15.76%
ROICexc growth 3Y4.44%
ROICexc growth 5Y15.37%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
F-Score6
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.92 | ||
| Cap/Depr | 130.74% | ||
| Cap/Sales | 49.05% | ||
| Interest Coverage | 2.1 | ||
| Cash Conversion | 78.06% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 | ||
| Altman-Z | 0.33 |
F-Score6
WACC5.92%
ROIC/WACC0.38
Cap/Depr(3y)104.54%
Cap/Depr(5y)153.18%
Cap/Sales(3y)38.39%
Cap/Sales(5y)55.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
Revenue Next Year1.4%
Revenue Next 2Y2.68%
Revenue Next 3Y3.92%
Revenue Next 5Y5.62%
EBIT growth 1Y-3.69%
EBIT growth 3Y11.4%
EBIT growth 5Y20.1%
EBIT Next Year254.56%
EBIT Next 3Y58.98%
EBIT Next 5Y35.87%
FCF growth 1Y-137.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.95%
OCF growth 3Y11.62%
OCF growth 5Y10.54%
HEALTHPEAK PROPERTIES INC / DOC FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
What is the valuation status for DOC stock?
ChartMill assigns a valuation rating of 1 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
Can you provide the profitability details for HEALTHPEAK PROPERTIES INC?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 5 / 10.
What is the valuation of HEALTHPEAK PROPERTIES INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for HEALTHPEAK PROPERTIES INC (DOC) is 48.7 and the Price/Book (PB) ratio is 1.58.
How sustainable is the dividend of HEALTHPEAK PROPERTIES INC (DOC) stock?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 1204.15%.